SHPH

Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the discovery and development of innovative therapeutic solutions that enhance the effectiveness of radiation therapy in cancer treatment. Through its subsidiary, Shuttle Pharmaceuticals, Inc., the company is dedicated to advancing its proprietary drug candidates designed to sensitize tumors to radiation, thereby improving patient outcomes. With a robust pipeline and a commitment to addressing unmet medical needs in oncology, Shuttle Pharmaceuticals is positioned to play a pivotal role in the evolution of cancer therapies.